Pricing Log in Create free account
Friday 6 November 2026 Export PNTG’s income statement to Excel — free account

The Pennant Group, Inc.

PNTG Healthcare Medical Care Facilities

The Pennant Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $947.7 million, up 36.3% from fiscal 2024.

Revenue
+32.0%
EPS
+55.6%
Free cash flow
−3.19%
Total debt
+662.8%

Quarter to September 2026, against a year earlier

37.77 2.23 −5.57%
Market cap
$1.4B
P/E
37.3×
Fwd P/E
36.7×
Dividend yield
—
F-score
5/9
Altman Z
2.29
Beneish M
−2.52
Dividend safety
n/a
Overview
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios

Insider Decisions last twelve months

Sold, $m 0.69
Trades a month
Jan 26 Apr 26 Jul 26 Oct 26
Buy — — — — — — — — — — — —
Sell — — — — — 1 — 2 3 — — —
Insider Ownership 5.27%

Capital & Financial Ratios $m

Size
Market Cap 1,400.00
Revenue ttm 1,174.92
Net income ttm 42.64
Free cash flow ttm 34.35
Net debt Q 179.94
Valuation
P/E 37.27 (above 35: high)
Forward P/E 36.70 (above 35: high)
Price / sales 1.15
Forward P/S Powerpack
Price / FCF 39.50
Price / book 3.23
Financial health
Current ratio Q 1.18
Debt / equity Q 0.47 (at or below 0.5: strong)
Interest coverage Q 4.56
Growth
Revenue growth Q +31.96% (above 0%: growing)
Operating income growth Q +61.28% (above 0%: growing)
EPS, this year +18.64% (at or above 15%: strong)
EPS, next year A +13.47%
Revenue, next year A +24.93% (at or above 10%: strong)
EPS, past 5 yrs +10.07%
EPS, next 5 yrs A +15.41% (at or above 15%: strong)

Green and red mark values outside typical ranges; (Q) is the latest quarter, (A) analysts’ estimates. How we judge →

Valuation vs history

EV/Sales, ten years
EV/Sales is 1.3×, against a ten-year median of 1.4×; over the ten years it ranged from 0.7× in 2023 to 4.2× in 2020.
P/E against its own 10 years 28.36%
10-year low 10-year high
P/S against its own 10 years 44.09%
10-year low 10-year high
P/B against its own 10 years 40.67%
10-year low 10-year high
EV/Sales against its own 10 years 43.36%
10-year low 10-year high
EV/FCF against its own 10 years 57.51%
10-year low 10-year high

Dividends

Yield
—
Annual rate
—
Payout ratio
—

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 6 24 17 18
Receivables 61 81 123 131
Inventory — — — —
Other — — — —
80 123 167 179
2023 2024 2025 Q'26
Payables 11 19 25 28
ST’ Debt — — 5 5
Other — — — —
72 102 147 152

Compound Annual Growth %

10y 5y 3y
Sales — 19.37% 26.05%
Cash Flow — (0.77%) 74.79%
Earnings — 13.44% 64.51%
Book Value — 29.90% 43.88%

Earnings Trends EPS, adjusted, against the consensus

Q3 FY26 Estimate 0.33 Actual 0.35

Earnings per share against the consensus, by quarter
Quarter Estimate Reported Result
Q4 FY25 0.31 0.34 Beat by 0.03
Q1 FY26 0.31 0.32 Beat by 0.01
Q2 FY26 0.33 0.36 Beat by 0.03
Q3 FY26 0.33 0.35 Beat by 0.02
Q4 FY26 0.36 — Reports 24 February 2027

EPS $

Mar Jun Sep Dec Year
’26 0.24 0.25 0.26 — —
’25 0.22 0.20 0.17 0.24 0.84
’24 0.16 0.18 0.20 0.16 0.70
’23 0.06 0.09 0.15 0.14 0.44
’22 0.03 (0.09) 0.16 0.12 0.22
’21 0.03 0.09 0.04 (0.08) 0.09
’20 0.10 0.15 0.15 0.13 0.52
Fiscal quarters ending in the months shown.

Revenue $m

Mar Jun Sep Dec Year
’26 285 298 302 — —
’25 210 220 229 289 948
’24 157 169 181 189 695
’23 126 132 140 146 545
’22 114 116 118 125 473
’21 106 110 112 112 440
’20 92 93 98 108 391
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 (3) 22 25 — —
’25 (21) 35 14 21 48
’24 1 10 8 21 39
’23 9 7 12 5 33
’22 (4) 9 8 (4) 9
’21 (7) (5) (1) (5) (18)
’20 2 41 10 (3) 50
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 (9) 15 10 — —
’25 (23) 32 10 17 36
’24 (3) 9 7 17 30
’23 7 5 11 3 25
’22 (6) 3 6 (8) (5)
’21 (8) (6) (3) (7) (25)
’20 (1) 38 8 (2) 43
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Ten-year view Analyst estimates Powerpack
Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 TTM Sep ’26 Trend 10 yrs 2026e 2027e 2028e Next 3/yr
Income, $m
Income, $m Revenue 217 251 286 339 391 440 473 545 695 948 1,175 +17.8% 1,184 1,276 1,340 +12.2%
Gross margin, % 11.71 12.91 14.84 13.18 14.04 11.05 12.38 12.30 13.49 13.77 13.71 +2.1 pt
EBT 13 15 21 5 18 3 9 20 31 46 57 +15.0%
EBT margin, % 5.98 6.14 7.21 1.55 4.58 0.62 1.88 3.59 4.51 4.81 4.88 (1.2) pt
Net income 8 10 16 3 16 2 7 14 24 34 43 +17.5%
Per share, $
Per share, $ Revenue 7.76 9.02 10.28 12.16 13.95 15.48 16.28 18.25 22.29 27.42 33.57 +15.1%
Earnings 0.28 0.36 0.58 0.11 0.56 0.09 0.23 0.45 0.72 0.86 1.04 +13.3%
Cash flow 0.59 0.62 0.84 0.34 1.79 (0.64) 0.31 1.11 1.26 1.40 1.84 +10.1%
Capex 0.00 (0.09) (0.13) (0.24) (0.26) (0.22) (0.49) (0.27) (0.29) (0.35) (0.86) n/m
Free cash flow 0.59 0.53 0.71 0.10 1.53 (0.86) (0.18) 0.84 0.97 1.05 0.98 +6.7%
Book value 0.00 0.00 2.35 2.55 3.61 4.02 4.32 4.87 10.00 10.83 11.99 n/m
Shares, m 28 28 28 28 28 28 29 30 31 35 35 +2.4%
Valuation, ×
Valuation, × P/E 37.31 37.31 37.31 312.57 101.86 288.50 46.87 31.56 36.83 32.36 37.27 96.2
P/S 1.30 1.30 1.30 2.72 4.16 1.49 0.66 0.78 1.19 1.03 1.15 1.6
P/B 4.98 4.98 4.98 12.95 16.09 5.74 2.49 2.91 2.65 2.60 3.23 6.0
EV/Sales 2.05 2.05 2.05 2.81 4.22 1.63 0.83 0.91 1.54 1.19 1.31 1.9
EV/FCF 47.09 47.09 47.09 334.86 38.41 (29.27) (76.23) 19.94 35.40 31.16 44.74 49.6
Cash, $m
Cash, $m Operating cash flow 16 17 23 10 50 (18) 9 33 39 48 65 +12.7%
Capex (3) (3) (4) (7) (7) (6) (14) (8) (9) (12) (30) +14.8%
Free cash flow 16 15 20 3 43 (25) (5) 25 30 36 34 +9.2%
Balance, $m
Balance, $m Working capital — 0 0 (13) (29) 4 4 9 21 20 27 +61.1%
Net debt — 0 0 30 22 62 77 58 (24) 157 180 n/m
Shareholders’ equity — — 65 71 101 114 126 146 312 374 420 +28.3%
Returns, %
Returns, % ROA 0.00 10.58 31.96 0.93 3.30 0.52 1.27 2.54 3.70 3.59 3.99 +3.6 pt
ROIC — 0.00 19.76 3.49 9.57 1.66 3.92 7.73 8.28 6.11 7.14 +6.1 pt
ROE 0.00 17.80 26.08 3.73 18.28 2.50 5.54 9.87 9.86 8.62 9.41 +8.6 pt
People
People Employees — — — — 5,223 6,441 5,335 5,791 7,000 9,700 — +13.2%
Revenue/emp, $m 0.00 0.00 0.00 0.00 0.07 0.07 0.09 0.09 0.10 0.10 — n/m
Negative figures in brackets.
estimates

All 10 years →

Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 4 Nov 2026

The Pennant Group, Inc. vs peers in Medical Care Facilities (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
ARDT Ardent Health, Inc. $2.2B 15.2× 12.8× +3.05% (above 0%: growing) n/m −23.49% (below 0%: shrinking) 100.00% 0.00% Compare
AGL Agilon Health, Inc. $1.9B — (loss-making) — (loss-making) +5.86% (above 0%: growing) n/m +234.38% (above 0%: growing) 0.00% 1.59% Compare
AMN AMN Healthcare Services Inc $1.8B 17.4× 25.4× +2.29% (above 0%: growing) +117.88% (above 0%: growing) −389.43% (below 0%: shrinking) 30.58% 4.00% Compare
HCSG Healthcare Services Group, Inc. $1.7B 16.6× 18.6× +3.29% (above 0%: growing) −37.29% (below 0%: shrinking) −59.81% (below 0%: shrinking) 16.76% 6.66% Compare
SNDA Sonida Senior Living, Inc. $1.6B — (loss-making) — (loss-making) +114.40% (above 0%: growing) n/m +360.11% (above 0%: growing) 35.68% (9.27%) Compare
USPH U.S. Physical Therapy, Inc. $1.5B — (loss-making) 45.8× +12.90% (above 0%: growing) n/m +32.17% (above 0%: growing) 19.34% 0.00% Compare
PNTG The Pennant Group, Inc. $1.4B 37.3× 36.7× +31.96% (above 0%: growing) +55.56% (above 0%: growing) −3.19% (below 0%: shrinking) 13.34% 5.46%
NUTX Nutex Health Inc. $1.3B 7.4× 7.3× −13.62% (below 0%: shrinking) n/m +19.44% (above 0%: growing) 67.04% 57.75% Compare
INNV InnovAge Holding Corp. $1.2B 124× 20.9× +12.14% (above 0%: growing) +155.00% (above 0%: growing) +622.82% (above 0%: growing) 24.02% 7.61% Compare
Median of peers $1.7B 16.6× 19.8× +4.58% +117.88% +25.81% 27.30% 2.80%

All 51 Medical Care Facilities stocks →

Pay and ownership Proxy statement filed 31 March 2026

Chief executive’s pay

Year Total pay Actually paid $100 invested
2025 3.74m 2.97m 48.00

Ownership

Directors and executive officers, together 6.90%
Van Berkom & Associates Inc. 9.00%
BlackRock, Inc. 6.30%
The Vanguard Group 5.10%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s shares at the start of the earliest year shown was worth at each year’s end. Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more. Read the proxy statement

The Pennant Group, Inc. (PNTG) Latest News

6 Nov

Impact 3 · · MarketBeat
Impact 3 · · Simply Wall St.

5 Nov

Impact 3 · · GuruFocus.com

4 Nov

Impact 3 · · GlobeNewswire

25 Sep

Impact 4 · · Simply Wall St.

24 Sep

Impact 4 · · StockStory

21 Sep

Impact 3 ·

16 Sep

Impact 3 ·

14 Sep

Impact 3 ·

4 Sep

Impact 3 ·

2 Sep

Impact 3 ·

19 Aug

Impact 3 · · MarketBeat

7 Aug

Impact 4 ·
Impact 3 · · MarketBeat transcript

6 Aug

Impact 4 ·

5 Aug

Impact 4 ·
Impact 3 ·
Impact 3 ·

4 Aug

Impact 3 ·

14 Jul

Impact 3 · · The Motley Fool

6 Jun

Impact 4 · · Simply Wall St.
Impact 3 · · Simply Wall St.

4 Jun

Impact 3 · · GlobeNewswire

18 May

Impact 3 · · Zacks

16 May

Impact 3 · · StockStory

8 May

Impact 4 · · MarketBeat

7 May

Impact 4 · · The Motley Fool transcript
Impact 4 · · Moby

6 May

Impact 4 · · Zacks
Impact 4 · · StockStory
stockrow.com/PNTG · Data as of Nov 4, 2026 · For information only; not investment advice. · © 2026 stockrow.com